Plain-English translation of NCT07741435 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a new blood test called Methylscape that looks for tiny chemical changes in DNA that often signal cancer. The test is designed to detect signals from many different cancer types using just one blood sample, along with urine and saliva samples. This study will help determine whether Methylscape could eventually be used as a simple screening tool for cancer in large populations.
Most cancers are not caught until they are advanced and harder to treat. This research exists because there is no reliable single test that can screen for multiple cancer types at once—a tool that could help doctors find cancer much earlier, when treatment is more effective.
You likely qualify if…
You likely don't qualify if…
If you have cancer, you will provide blood, urine, saliva, and tissue samples at your initial visit. If you are cancer-free, you will provide blood, urine, and saliva samples once. Some early-stage cancer patients may be asked to return every 6 months for follow-up blood and urine tests to see if the test can detect cancer recurrence. All samples are processed and stored securely for testing.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
Colombia